Eric M. Dube, Chief Executive Officer at Travere Therapeutics, Inc. (TVTX), sold 14,344 shares at $14.89 ($211K) on 2021-06-01, disclosed to the SEC on 2021-06-03.
Open-market sale of $211k TVTX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.89 | 4,782 | $71K | 33.7% |
| 2 | $14.89 | 4,782 | $71K | 33.7% |
| 3 | $14.35 | 4,780 | $69K | 32.5% |
| Total | $14.71 avg | 14,344 | $211K | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $2.6M | — | Filing → |
| TVTX | SELL | 2026-04-02 | $1.9M | — | Filing → |
| TVTX | SELL | 2026-02-24 | $1.8M | — | Filing → |